All Pharma News
CytoImmune to Present Preclinical Data Highlighting Potential of TRACK-NK Cells

CytoImmune to Present Preclinical Data Highlighting Potential of TRACK-NK Cells
BUSINESSWIRE
10 Nov 2022
Share Share
CytoImmune Therapeutics Appoints Remus Vezan as Chief Medical Officer

CytoImmune Therapeutics Appoints Remus Vezan as Chief Medical Officer
BUSINESSWIRE
07 Sep 2022
Share Share
CytoImmune and City of Hope Begin Dosing in PI Trial Evaluating NKCT

CytoImmune and City of Hope Begin Dosing in PI Trial Evaluating NKCT
BUSINESSWIRE
28 Jul 2022
Share Share
CytoImmune Presents Data on NK Cell-Based Therapies for Hematology & Solid Tumor

CytoImmune Presents Data on NK Cell-Based Therapies for Hematology & Solid Tumor
BUSINESSWIRE
11 Apr 2022
Share Share
CytoImmune to Participate in Upcoming April Investor Conferences

CytoImmune to Participate in Upcoming April Investor Conferences
BUSINESSWIRE
07 Apr 2022
Share Share
CytoImmune Tx Opens Company’s Clinical Cell Manufacturing Facility in Toa Baja

CytoImmune Tx Opens Company’s Clinical Cell Manufacturing Facility in Toa Baja
BUSINESSWIRE
24 Mar 2022
Share Share
CytoImmune to Present New Preclinical Data on TRACK-NK Cell Therapies

CytoImmune to Present New Preclinical Data on TRACK-NK Cell Therapies
BUSINESSWIRE
08 Mar 2022
Share Share
CytoImmune CEO breaks down her 3 `pillars` of success; Novartis, and more

CytoImmune CEO breaks down her 3 `pillars` of success; Novartis, and more
Alex Hoffmann\nKathy Wong\nPaul Schloesser ENDPTS
12 Nov 2021
Share Share
CytoImmune Therapeutics Welcomes Aleksey Krylov, Chief Financial Officer

CytoImmune Therapeutics Welcomes Aleksey Krylov, Chief Financial Officer
PR NEWSWIRE
26 Jun 2021
Share Share
CytoImmune Therapeutics Welcomes Aleksey Krylov, Chief Financial Officer

CytoImmune Therapeutics Welcomes Aleksey Krylov, Chief Financial Officer
PR NEWSWIRE
26 Jun 2021
Share Share